Tuesday, Dec 3, 2024 · SEC filings
What the smart money revealed on Dec 3
1,026 insider filings came in. We hid 145 planned (10b5-1) sellers and 689 people whose filings were routine, like grants and tax withholding.
Prospect Capital (PSEC) COO M. Grier Eliasek bought $1.01M
210,000 shares on the open market. Not a grant or an option exercise. Their past buys: 0 of 5 checked quarters beat the typical stock 6 months later.
Accelerate Diagnostics (AXDX) Director John Patience bought $314K
200,000 shares on the open market. Not a grant or an option exercise.
Nuveen Churchill Direct Lending (NCDL) CEO and President Kenneth Kencel bought $174K
10,000 shares on the open market. Not a grant or an option exercise. Their past buys: 0 of 5 checked quarters beat the typical stock 6 months later.
Calamos Aksia Alternative Credit & Income Fund (CAPIX) Vice President John Koudounis bought $125K
11,715 shares on the open market. Not a grant or an option exercise.
Universal Technical Institute (UTI) Director Adam Gray sold $62.3M
Not marked as a planned 10b5-1 sale. Sold 27% of the shares they held directly. Still holds 6.85M shares.
Altice USA (OPTU) Director Patrick Drahi sold $19.7M
Not marked as a planned 10b5-1 sale. Sold 4% of the shares they held directly. Still holds 18.73M shares.
Las Vegas Sands (LVS) Chairman and CEO Robert Goldstein sold $3.19M
Not marked as a planned 10b5-1 sale. Sold every share held directly.
Show 31 more real buys
Show 129 more real sales
13F season
Holdings as of Sep 30, 2024 were due Nov 14
58 funds have filed. 54 filed for the quarter before.
Biggest real insider buys, Nov 27–Dec 3
Open-market buys by officers and directors, filed in the 7 days up to Dec 3.
Free weekly email
Each week's biggest real insider buys, cluster buys and fund moves, every one dated. One email a week. Unsubscribe in one click.